Ampersand Capital Partners

Investor type

PE

Founded

1988

AUM

$3 000 M

Location

Boston, Massachusetts, United States

$50-100 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Founded in 1988, Ampersand is a middle-market private equity firm with $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, Amsterdam and London, Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.

Consistent with our theme of increasing specialization as a source of differentiated performance, Ampersand’s Healthcare portfolio has been focused around several overlapping industry clusters where our multiple prior successes give us a competitive edge. Most of our portfolio companies have revenues between $10 and $200 million at the time of Ampersand’s investment. We typically invest between $10 and $200 million and years of operational expertise to drive each investment toward success.

Ampersand’s team has decades of operating experience in Healthcare companies and over 150 years of shared private equity experience. Our unusual combination of skills, including deep industry, technical, financial, operating, and transactional capabilities, make us a preferred partner for entrepreneurs because we can contribute to their success on multiple levels.

At our roots, we are company-builders, not investment managers. Our experience gives us empathy for our CEOs and helps us understand the challenges they face. This ability to identify, and contribute to, problem resolution makes us very effective in our companies.

Industry

Healthcare Services Marketing and Advertising Software Telecommunications MedTech Life Sciences HealthTech Media and Entertainment Food and Beverage Foodtech

Region of investment

Europe North America

Ampersand Capital Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Ampersand 2014 Limited Partnership
Venture Capital (VC)
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$110 M
March 2014
Ampersand 2018 Limited Partnership
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$450 M
March 2018
Ampersand 2022 Limited Partnership
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$1200 M
August 2022
Ampersand 2026 (“AMP-26”) Limited Partnership
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
Telecommunications
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$1500 M
May 2026

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
iXf3CWzjTaxFusmR iXf3CWzjTaxFusmR
iXf3CWzjTaxFusmR
avatar
iXf3CWzjTaxFusmR iXf3CWzjTaxFusmR
iXf3CWzjTaxFusmR
avatar
iXf3CWzjTaxFusmR iXf3CWzjTaxFusmR
iXf3CWzjTaxFusmR
avatar
iXf3CWzjTaxFusmR iXf3CWzjTaxFusmR
iXf3CWzjTaxFusmR
avatar
iXf3CWzjTaxFusmR iXf3CWzjTaxFusmR
iXf3CWzjTaxFusmR
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Ampersand Capital Partners

Ampersand Capital Partners is located in Boston, Massachusetts, United States.
Ampersand Capital Partners was founded in 1988.
Ampersand Capital Partners invests in companies and startups in Healthcare Services, Marketing and Advertising, Software, Telecommunications, MedTech, Life Sciences, HealthTech, Media and Entertainment, Food and Beverage, Foodtech.
Ampersand Capital Partners invests in companies and startups in Europe, North America.
Ampersand Capital Partners invests in companies and startups at Seed, Series B, Series A.
Ampersand Capital Partners usually invests $50-100 m on average.
Ampersand Capital Partners has around $3 000m assets under management.
Ampersand Capital Partners last fund was created/launched in 2026-05-28